Exploring new methods in cell and gene therapy education and application
Biology and Biotechnology of Cell and Gene Therapy
This study is exploring new ways to combine engineering and medical science to improve gene and cell therapies, which could lead to better treatments for serious health issues by making them more effective and easier to deliver.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10869880 on NIH RePORTER |
What this research studies
This research focuses on developing innovative educational approaches that integrate engineering and biomedical sciences to advance the field of gene and cell therapy. It addresses the challenges of delivering genetic materials effectively and improving the potency of therapeutic payloads like CRISPR/Cas9. By enhancing our understanding of stem cell behavior and the signals that control their function, the research aims to unlock new applications in regenerative medicine and tissue engineering. Patients may benefit from advancements in therapies that could provide long-term solutions for serious medical conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions that could be treated with advanced gene and cell therapies, particularly those involving genetic interventions.
Not a fit: Patients with conditions that do not involve genetic components or those who are not candidates for gene or cell therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective gene and cell therapies that provide long-lasting treatment options for patients with serious health conditions.
How similar studies have performed: Other research in the field of gene and cell therapy has shown promise, indicating that innovative educational and methodological approaches can lead to significant advancements.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Schaffer, David V — University of California Berkeley
- Study coordinator: Schaffer, David V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.